In the tumor environment, TGF-ß acts as the major immunosuppressive cytokine and signals tumor progression, at the same time initiating CXCL13 expression in exhausted CD8+ T cells, synonymous for an escalation of the anti-tumor immune response [15]. The gene discussed is CXCL13; the disease is neoplasm.